Literature DB >> 1964843

Conditional hypoalgesia is attenuated by naltrexone applied to the periaqueductal gray.

F J Helmstetter1, J Landeira-Fernandez.   

Abstract

The ventrolateral periaqueductal gray (vPAG) is an important component in a brainstem system involved in the endogenous modulation of nociception and defensive behavior. The present study was conducted to determine if opioid receptors within the vPAG contribute to the hypoalgesia seen in rats during presentation of a Pavlovian CS for footshock. Independent groups of animals received microinjections of either 5.0 micrograms naltrexone HCl or vehicle into the vPAG prior to being placed in an observation chamber in which shock had been delivered 24 h earlier. Nociceptive reactivity was measured with the formalin test. Naltrexone treatment attenuated conditional hypoalgesia but did not affect formalin-induced behavior in non-shocked rats. Naltrexone had no effect on the amount of defensive freezing behavior observed during the test session. These results indicate that conditional hypoalgesia as measured by the formalin test involves the activation of documented brainstem antinociceptive systems.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1964843     DOI: 10.1016/0006-8993(90)90343-a

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

Review 1.  Macromolecular synthesis, distributed synaptic plasticity, and fear conditioning.

Authors:  Fred J Helmstetter; Ryan G Parsons; Georgette M Gafford
Journal:  Neurobiol Learn Mem       Date:  2007-10-31       Impact factor: 2.877

2.  Neural organization of the defensive behavior system responsible for fear.

Authors:  M S Fanselow
Journal:  Psychon Bull Rev       Date:  1994-12

3.  Amygdalar NMDA receptors are critical for new fear learning in previously fear-conditioned rats.

Authors:  H Lee; J J Kim
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

4.  The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone.

Authors:  W M Olango; M Roche; G K Ford; B Harhen; D P Finn
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 5.  Mechanisms of placebo analgesia: A dual-process model informed by insights from cross-species comparisons.

Authors:  Scott M Schafer; Stephan Geuter; Tor D Wager
Journal:  Prog Neurobiol       Date:  2017-11-03       Impact factor: 11.685

Review 6.  The central nucleus of the amygdala and the construction of defensive modes across the threat-imminence continuum.

Authors:  Justin M Moscarello; Mario A Penzo
Journal:  Nat Neurosci       Date:  2022-08-01       Impact factor: 28.771

7.  Loss of dopamine D1 receptors and diminished D1/5 receptor-mediated ERK phosphorylation in the periaqueductal gray after spinal cord lesion.

Authors:  Pamela J Voulalas; Yadong Ji; Li Jiang; Jamila Asgar; Jin Y Ro; Radi Masri
Journal:  Neuroscience       Date:  2016-12-05       Impact factor: 3.590

8.  Design of a neurally plausible model of fear learning.

Authors:  Franklin B Krasne; Michael S Fanselow; Moriel Zelikowsky
Journal:  Front Behav Neurosci       Date:  2011-07-26       Impact factor: 3.558

9.  Regulation of extinction-related plasticity by opioid receptors in the ventrolateral periaqueductal gray matter.

Authors:  Ryan G Parsons; Georgette M Gafford; Fred J Helmstetter
Journal:  Front Behav Neurosci       Date:  2010-08-03       Impact factor: 3.558

10.  Behavioral consequences of delta-opioid receptor activation in the periaqueductal gray of morphine tolerant rats.

Authors:  Michael M Morgan; Michelle D Ashley; Susan L Ingram; MacDonald J Christie
Journal:  Neural Plast       Date:  2009-02-25       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.